Florida Senate
-
2025
CS for SB 524
By
the Appropriations Committee on Health and Human Services;
and Senator Harrell
31-00466-25 2025524__603-03443-25 2025524c1
1 A bill to be entitled
2 An act relating to newborn screenings; amending s.
3 383.14, F.S.; subject to legislative appropriation and
34 383.14, F.S.; beginning on a specified date, requiring that the
45 that the Department of Health’s rules require that newborns be
56 newborns be screened for Duchenne muscular dystrophy at the
67 at the appropriate age; providing an effective date.
7
8
89 Be It Enacted by the Legislature of the State of Florida:
9
10
1011 Section 1. Paragraph (a) of subsection (2) of section
1112 383.14, Florida Statutes, is amended to read:
1213 383.14 Screening for metabolic disorders, other hereditary
1314 and congenital disorders, and environmental risk factors.—
1415 (2) RULES.—
1516 (a) After consultation with the Genetics and Newborn
1617 Screening Advisory Council, the department shall adopt and
1718 enforce rules requiring that every newborn in this state shall:
1819 1. Before becoming 1 week of age, have a blood specimen
1920 collected for newborn screenings;
2021 2. Be tested for any condition included on the federal
2122 Recommended Uniform Screening Panel which the council advises
2223 the department should be included under the state’s screening
2324 program. After the council recommends that a condition be
2425 included, the department shall submit a legislative budget
2526 request to seek an appropriation to add testing of the condition
2627 to the newborn screening program. The department shall expand
2728 statewide screening of newborns to include screening for such
2829 conditions within 18 months after the council renders such
2930 advice, if a test approved by the United States Food and Drug
3031 Administration or a test offered by an alternative vendor is
3132 available. If such a test is not available within 18 months
3233 after the council makes its recommendation, the department shall
3334 implement such screening as soon as a test offered by the United
3435 States Food and Drug Administration or by an alternative vendor
3536 is available; and
3637 3. At the appropriate age, be tested for such other
3738 metabolic diseases and hereditary or congenital disorders as the
3839 department may deem necessary.
Beginning January 1, 2027, the
39
rules must require that newborns be screened for Duchenne
Subject to legislative
40
appropriation, beginning January 1, 2027, the rules must require
41
that newborns be screened for Duchenne muscular dystrophy at the
42
muscular dystrophy at the appropriate age.
4143 Section 2. This act shall take effect July 1, 2025.